Phase 2 trial of utility and safety for bevacizumab in combination with adjuvant chemotherapy in cervical cancer
Not Applicable
- Conditions
- Cervical cancer
- Registration Number
- JPRN-UMIN000026986
- Lead Sponsor
- Osaka medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients have severe fever. 2)Patients have a hystory acute myocardial infarction. 3)Patients have ileus symptom. 4)Patients have poor control of DM and HT and VTE.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method